A top F.D.A. regulator said there was compelling data for redesigned coronavirus vaccines from Pfizer-BioNTech and Moderna.
View original article
Contributor: Sharon LaFraniere and Noah Weiland
A top F.D.A. regulator said there was compelling data for redesigned coronavirus vaccines from Pfizer-BioNTech and Moderna.
View original article
Contributor: Sharon LaFraniere and Noah Weiland